FDA NDC Directory · JSON-LD · Markdown
NDC 70069-747 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION
| Labeler / Manufacturer | Somerset Therapeutics, LLC |
|---|---|
| Marketing category | Abbreviated NDA (generic) · App ANDA217726 |
| Dosage form / route | INJECTION, SOLUTION · INTRAVENOUS |
| Active ingredients | DIBASIC POTASSIUM PHOSPHATE (236 mg/mL) MONOBASIC POTASSIUM PHOSPHATE (224 mg/mL) |
| Marketing started | 20240711 |
| Package count | 1 |
Source: openFDA. Public-domain (CC0).